Status:
WITHDRAWN
Monitoring of Corticosteroids Induced Immunosuppression Using Monocyte Human Leukocyte Antigen-DR (mHLA-DR).
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Immunosuppression
Eligibility:
All Genders
18+ years
Brief Summary
Corticotherapy is widely used in auto-immune diseases. If induced immunosuppression by corticosteroids is well admitted, it's currently not possible to determine individual risk of infection. Thus, th...
Eligibility Criteria
Inclusion
- Patient aged of 18 years old or more, male or female.
- Patient diagnosed with any pathology indicating a treatment by corticotherapy at 1mg/kg/day.
- Patient who didn't express any opposition to be enrolled in the study after reading the dedicated information letter.
- Patient affiliated to social heath care regimen
Exclusion
- Treatment by corticosteroids in the previous 6 months.
- Immunsuppressive treatment (except for corticosteroids) in the previous 2 years.
- Patient under judicial protection, guardianship or curators
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04360772
Start Date
January 1 2023
End Date
September 1 2023
Last Update
February 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.